Philip A. Pizzo, M.D.

Publication Details

  • TRICHOSPORON-BEIGELII, AN EMERGING PATHOGEN RESISTANT TO AMPHOTERICIN-B JOURNAL OF CLINICAL MICROBIOLOGY Walsh, T. J., Melcher, G. P., Rinaldi, M. G., LECCIONES, J., MCGOUGH, D. A., Kelly, P., Lee, J., Callender, D., Rubin, M., Pizzo, P. A. 1990; 28 (7): 1616-1622


    Trichosporon beigelii caused fatal disseminated infections that were resistant to amphotericin B in two granulocytopenic patients. In vitro susceptibility studies demonstrated that both index strains of T. beigelii were inhibited but not killed by amphotericin B at achievable concentrations in serum. The minimum lethal concentration for both isolates was greater than or equal to 18 micrograms/ml. Five of seven other isolates were found to have a similar pattern of amphotericin B resistance. The fact that the minimum lethal concentration of T. beigelii was many times greater than its MIC was consistent with a resistance pattern of tolerance. We concluded that T. beigelii may be resistant in vitro to amphotericin B and that this in vitro resistance was correlated with refractory, disseminated trichosporonosis in granulocytopenic patients. T. beigelii should be included in the expanding list of amphotericin B-resistant fungi.

    View details for Web of Science ID A1990DK19400025

    View details for PubMedID 2380383

Stanford Medicine Resources:

Footer Links: